InvestorsHub Logo
Followers 8
Posts 628
Boards Moderated 0
Alias Born 05/26/2021

Re: None

Thursday, 09/02/2021 12:41:29 AM

Thursday, September 02, 2021 12:41:29 AM

Post# of 13742
https://www.biospace.com/article/releases/medolife-s-therapeutic-scorpion-peptide-proves-successful-in-treating-covid-19-patients-in-dominican-republic-study/

https://www.globenewswire.com/news-release/2021/05/04/2222245/0/en/Medolife-Rx-Announces-Historic-Product-Registration-in-Dominican-Republic-Enabling-Escozine-to-Be-Sold-Throughout-Latin-America-as-Natural-Alternative-Cancer-Medicine.html

Two of many great articles … “know what you own” they say, I’m facinated by not only their science data products and patents but also by their prudent pragmatic aligning with other companies for production - brilliant chess moves if you will … for me, this stock is an investment, no secret there .. investment in the science and the future … sure, I’m hopeful to profit exponentially along with everyone else - however, I believe this company’s patented technology, escozine & many products on the horizon have the ability to help a lot of people world wide .. the scorpion farm will help reduce costs fir inventory & as well become a source of income enabling them to sell scorpion venom to other research companies as a product … QNTA Medolife rx AELIA business model is shaping up beautifully.. we just need paytience while we wait for inventory to get on the shelves…
I see lots of yelling about Promoting.. it’d be counterintuitive to blast the air waves before a product is on the shelf … the last cc it was mentioned the number of stores, also was mentioned the products that will be ordered in Mexico it was also mentioned the status of escozine in the DR being available…
I’m glad I went looking for news, as thought I’ve read the above articles before - rereading them reminds me why I bought in the first place - GLTA
QNTA $$$ In my humble opinion, staying long will pay off … imo ;)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.